Charles Raymond Eck is a notable inventor based in Shrewsbury, MA (US). He holds a total of 5 patents that focus primarily on cannabinoid formulations for inhalation. His innovative work has contributed significantly to the field of cannabinoid delivery systems.

Latest Patents

Eck's latest patents include groundbreaking formulations for cannabinoid inhalation. One of his notable inventions is a cannabinoid active agent containing formulation that comprises the active agent, an HFA propellant, and optionally a terpenoid and a co-solvent. This formulation requires at least two cannabinoids, each present in amounts of at least 20% of the total cannabinoid content. Additionally, he has developed a low-temperature inhalation method that allows for the administration of cannabinoid entities without the use of heat greater than 40°C. Another patent focuses on a cannabinoid material as an active agent, which also utilizes an HFA propellant and a co-solvent, with an inhalation method that does not exceed 50°C.

Career Highlights

Throughout his career, Charles Raymond Eck has worked with various companies, including Ep Pharma, LLC and Synthe Tech Inc. His contributions to cannabinoid research and development have positioned him as a key figure in this innovative field.

Collaborations

Eck has collaborated with notable individuals in the industry, including Christopher L Pelloni and Paul C Ahrens. These partnerships have further enhanced his research and development efforts.

Conclusion

Charles Raymond Eck's work in cannabinoid formulations showcases his innovative spirit and dedication to advancing inhalation technologies. His patents reflect a commitment to improving cannabinoid delivery methods, making significant strides in the field.